{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:52:09Z","timestamp":1792759929339,"version":"4.5.0"},"reference-count":189,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/1673-5374.355747","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T02:04:26Z","timestamp":1666836266000},"page":"947","source":"Crossref","is-referenced-by-count":35,"title":["The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer\u2019s disease"],"prefix":"10.4103","volume":"18","author":[{"given":"Cun-Gen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ge","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Zhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.355747-1","unstructured":"Ahn JW, Jang SK, Jo BR, Kim HS, Park JY, Park HY, Yoo YM, Joo SS (2021) A therapeutic intervention for Alzheimer\u2019s disease using ginsenoside Rg3: its role in M2 microglial activation and non-amyloidogenesis. J Physiol Pharmacol doi: 10.26402\/jpp.2021.2.04."},{"key":"key-10.4103\/1673-5374.355747-2","doi-asserted-by":"crossref","unstructured":"Alexandrov PN, Zhao Y, Jones BM, Bhattacharjee S, Lukiw WJ (2013) Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line. J Inorg Biochem 128:267-269.","DOI":"10.1016\/j.jinorgbio.2013.05.010"},{"key":"key-10.4103\/1673-5374.355747-3","doi-asserted-by":"crossref","unstructured":"Anwar S, Rivest S (2020) Alzheimer\u2019s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Expert Opin Ther Targets 24:331-344.","DOI":"10.1080\/14728222.2020.1738391"},{"key":"key-10.4103\/1673-5374.355747-4","doi-asserted-by":"crossref","unstructured":"Arranz AM, De Strooper B (2019) The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications. Lancet Neurol 18:406-414.","DOI":"10.1016\/S1474-4422(18)30490-3"},{"key":"key-10.4103\/1673-5374.355747-5","unstructured":"Ashtari F, Madanian R, Shaygannejad V, Zarkesh SH, Ghadimi K (2019) Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects. Int J Physiol Pathophysiol Pharmacol 11:267-273."},{"key":"key-10.4103\/1673-5374.355747-6","doi-asserted-by":"crossref","unstructured":"Babi\u0107 Leko M, Nikolac Perkovi\u0107 M, Klepac N, \u0160trac D\u0160, Borove\u010dki F, Pivac N, Hof PR, \u0160imi\u0107 G (2020) IL-1\u03b2, IL-6, IL-10, and TNF\u03b1 single nucleotide polymorphisms in human influence the susceptibility to Alzheimer\u2019s disease pathology. J Alzheimers Dis 75:1029-1047.","DOI":"10.3233\/JAD-200056"},{"key":"key-10.4103\/1673-5374.355747-7","doi-asserted-by":"crossref","unstructured":"Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, Kohsaka S, Jucker M, Calhoun ME (2008) Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28:4283-92.","DOI":"10.1523\/JNEUROSCI.4814-07.2008"},{"key":"key-10.4103\/1673-5374.355747-8","doi-asserted-by":"crossref","unstructured":"Browne TC, McQuillan K, McManus RM, O\u2019Reilly JA, Mills KH, Lynch MA (2013) IFN-\u03b3 Production by amyloid \u03b2-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease. J Immunol 190:2241-2251.","DOI":"10.4049\/jimmunol.1200947"},{"key":"key-10.4103\/1673-5374.355747-9","doi-asserted-by":"crossref","unstructured":"Bruce KD, Gorkhali S, Given K, Coates AM, Boyle KE, Macklin WB, Eckel RH (2018) Lipoprotein lipase is a feature of alternatively-activated microglia and may facilitate lipid uptake in the CNS during demyelination. Front Mol Neurosci 11:57.","DOI":"10.3389\/fnmol.2018.00057"},{"key":"key-10.4103\/1673-5374.355747-10","doi-asserted-by":"crossref","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T (2020) The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 21:7452.","DOI":"10.3390\/ijms21207452"},{"key":"key-10.4103\/1673-5374.355747-11","doi-asserted-by":"crossref","unstructured":"Byun CJ, Seo J, Jo SA, Park YJ, Klug M, Rehli M, Park MH, Jo I (2011) DNA methylation of the 5\u2019-untranslated region at +298 and +351 represses BACE1 expression in mouse BV-2 microglial cells. Biochem Biophys Res Commun 417:387-92.","DOI":"10.1016\/j.bbrc.2011.11.123"},{"key":"key-10.4103\/1673-5374.355747-12","doi-asserted-by":"crossref","unstructured":"Cao C, Arendash GW, Dickson A, Mamcarz MB, Lin X, Ethell DW (2009) Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer\u2019s mice without infiltrating the CNS. Neurobiol Dis 34:63-70.","DOI":"10.1016\/j.nbd.2008.12.015"},{"key":"key-10.4103\/1673-5374.355747-13","doi-asserted-by":"crossref","unstructured":"Carosi JM, Sargeant TJ (2019) Rapamycin and Alzheimer disease: a double-edged sword?. Autophagy15:1460-1462.","DOI":"10.1080\/15548627.2019.1615823"},{"key":"key-10.4103\/1673-5374.355747-14","doi-asserted-by":"crossref","unstructured":"Castellani G, Schwartz M (2020) Immunological features of non-neuronal brain cells: implications for Alzheimer\u2019s disease immunotherapy. Trends Immunol 41:794-804.","DOI":"10.1016\/j.it.2020.07.005"},{"key":"key-10.4103\/1673-5374.355747-15","doi-asserted-by":"crossref","unstructured":"Celarain N, S\u00e1nchez-Ruiz de Gordoa J, Zelaya MV, Rold\u00e1n M, Larumbe R, Pulido L, Echavarri C, Mendioroz M (2016) TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus. Clin Epigenetics 8:37.","DOI":"10.1186\/s13148-016-0202-9"},{"key":"key-10.4103\/1673-5374.355747-16","doi-asserted-by":"crossref","unstructured":"Charri\u00e8re K, Ghzaiel I, Lizard G, Vejux A (2021) Involvement of microglia in neurodegenerative diseases: beneficial effects of docosahexahenoic acid (DHA) supplied by food or combined with nanoparticles. Int J Mol Sci 22:10639.","DOI":"10.3390\/ijms221910639"},{"key":"key-10.4103\/1673-5374.355747-17","doi-asserted-by":"crossref","unstructured":"Chavda V, Singh K, Patel V, Mishra M, Mishra AK (2022) Neuronal glial crosstalk: specific and shared mechanisms in Alzheimer\u2019s disease. Brain Sci 12:75.","DOI":"10.3390\/brainsci12010075"},{"key":"key-10.4103\/1673-5374.355747-18","doi-asserted-by":"crossref","unstructured":"Chen S, Wang T, Yao J, Brinton RD (2020) Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo: therapeutic implication for Alzheimer\u2019s disease. Neurotherapeutics 17:1813-1824.","DOI":"10.1007\/s13311-020-00874-x"},{"key":"key-10.4103\/1673-5374.355747-19","doi-asserted-by":"crossref","unstructured":"Chhor V, Le Charpentier T, Lebon S, Or\u00e9 MV, Celador IL, Josserand J, Degos V, Jacotot E, Hagberg H, S\u00e4vman K, Mallard C, Gressens P, Fleiss B (2013) Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun 32:70-85.","DOI":"10.1016\/j.bbi.2013.02.005"},{"key":"key-10.4103\/1673-5374.355747-20","doi-asserted-by":"crossref","unstructured":"Chidambaram H, Das R, Chinnathambi S (2022) G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia. Eur J Cell Biol 101:151201.","DOI":"10.1016\/j.ejcb.2022.151201"},{"key":"key-10.4103\/1673-5374.355747-21","doi-asserted-by":"crossref","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL (2018) The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J Alzheimers Dis 64:S567-S610.","DOI":"10.3233\/JAD-179941"},{"key":"key-10.4103\/1673-5374.355747-22","doi-asserted-by":"crossref","unstructured":"Cornell J, Salinas S, Huang HY, Zhou M (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17:705-716.","DOI":"10.4103\/1673-5374.322423"},{"key":"key-10.4103\/1673-5374.355747-23","doi-asserted-by":"crossref","unstructured":"Cummings J, Lee G, Ritter A, Zhong K (2018) Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimers Dement 4:195-214.","DOI":"10.1016\/j.trci.2018.03.009"},{"key":"key-10.4103\/1673-5374.355747-24","doi-asserted-by":"crossref","unstructured":"Czapski GA, Strosznajder JB (2021) Glutamate and GABA in microglia-neuron cross-talk in Alzheimer\u2019s disease. Int J Mol Sci 22:11677.","DOI":"10.3390\/ijms222111677"},{"key":"key-10.4103\/1673-5374.355747-25","doi-asserted-by":"crossref","unstructured":"D\u2019Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 25:675-683.","DOI":"10.1016\/j.neurobiolaging.2003.12.026"},{"key":"key-10.4103\/1673-5374.355747-26","doi-asserted-by":"crossref","unstructured":"Das R, Chinnathambi S (2020) Actin-mediated microglial chemotaxis via g-protein coupled purinergic receptor in Alzheimer\u2019s disease. Neuroscience 448:325-336.","DOI":"10.1016\/j.neuroscience.2020.09.024"},{"key":"key-10.4103\/1673-5374.355747-27","doi-asserted-by":"crossref","unstructured":"Das R, Chinnathambi S (2021) Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis. Traffic 22:153-170.","DOI":"10.1111\/tra.12784"},{"key":"key-10.4103\/1673-5374.355747-28","doi-asserted-by":"crossref","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164:603- 615.","DOI":"10.1016\/j.cell.2015.12.056"},{"key":"key-10.4103\/1673-5374.355747-29","doi-asserted-by":"crossref","unstructured":"Delpech JC, Herron S, Botros MB, Ikezu T (2019) Neuroimmune crosstalk through extracellular vesicles in health and disease. Trends Neurosci 42:361-372.","DOI":"10.1016\/j.tins.2019.02.007"},{"key":"key-10.4103\/1673-5374.355747-30","doi-asserted-by":"crossref","unstructured":"Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ (2010) Early oligodendrocyte\/myelin pathology in Alzheimer\u2019s disease mice constitutes a novel therapeutic target. Am J Pathol 177:1422-1435.","DOI":"10.2353\/ajpath.2010.100087"},{"key":"key-10.4103\/1673-5374.355747-31","doi-asserted-by":"crossref","unstructured":"Devanney NA, Stewart AN, Gensel JC (2020) Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol 329:113310.","DOI":"10.1016\/j.expneurol.2020.113310"},{"key":"key-10.4103\/1673-5374.355747-32","doi-asserted-by":"crossref","unstructured":"Dietrich K, Bouter Y, M\u00fcller M, Bayer TA (2018) Synaptic alterations in mouse models for Alzheimer disease-a special focus on n-truncated Abeta 4-42. Molecules 23:718.","DOI":"10.3390\/molecules23040718"},{"key":"key-10.4103\/1673-5374.355747-33","doi-asserted-by":"crossref","unstructured":"Dionisio-Santos DA, Olschowka JA, O\u2019Banion MK (2019) Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J Neuroinflammation 16:74.","DOI":"10.1186\/s12974-019-1453-0"},{"key":"key-10.4103\/1673-5374.355747-34","doi-asserted-by":"crossref","unstructured":"Domingues C, da Cruz E Silva OAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks. Curr Alzheimer Res 14:870-882.","DOI":"10.2174\/1567205014666170317113606"},{"key":"key-10.4103\/1673-5374.355747-35","unstructured":"Dong XH, Chai XQ (2013) Alzheimer\u2019s disease transgenic animal models:How to get more similar pathological characteristics? Zhongguo Zuzhi Gongcheng Yanjiu 46:8075-8082."},{"key":"key-10.4103\/1673-5374.355747-36","doi-asserted-by":"crossref","unstructured":"Doran AC, Yurdagul A Jr, Tabas I (2020) Efferocytosis in health and disease. Nat Rev Immunol 20:254-267.","DOI":"10.1038\/s41577-019-0240-6"},{"key":"key-10.4103\/1673-5374.355747-37","doi-asserted-by":"crossref","unstructured":"Doust YV, King AE, Ziebell JM (2021) Implications for microglial sex differences in tau-related neurodegenerative diseases. Neurobiol Aging 105:340-348.","DOI":"10.1016\/j.neurobiolaging.2021.03.010"},{"key":"key-10.4103\/1673-5374.355747-38","doi-asserted-by":"crossref","unstructured":"Ernest James Phillips T, Maguire E (2021) Phosphoinositides: roles in the development of microglial-mediated neuroinflammation and neurodegeneration. Front Cell Neurosci 15:652593.","DOI":"10.3389\/fncel.2021.652593"},{"key":"key-10.4103\/1673-5374.355747-39","doi-asserted-by":"crossref","unstructured":"Evans FL, Dittmer M, de la Fuente AG, Fitzgerald DC (2019) Protective and regenerative roles of T cells in central nervous system disorders. Front Immunol 10:2171.","DOI":"10.3389\/fimmu.2019.02171"},{"key":"key-10.4103\/1673-5374.355747-40","doi-asserted-by":"crossref","unstructured":"Fakhoury M (2018) Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Curr Neuropharmacol 16:508-518.","DOI":"10.2174\/1570159X15666170720095240"},{"key":"key-10.4103\/1673-5374.355747-41","doi-asserted-by":"crossref","unstructured":"Fan Y, Xie L, Chung CY (2017) Signaling pathways controlling microglia chemotaxis. Mol Cells 40:163-168.","DOI":"10.14348\/molcells.2017.0011"},{"key":"key-10.4103\/1673-5374.355747-42","doi-asserted-by":"crossref","unstructured":"Ferrer I (2018) Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: the forgotten partner. Prog Neurobiol 169:24-54.","DOI":"10.1016\/j.pneurobio.2018.07.004"},{"key":"key-10.4103\/1673-5374.355747-43","doi-asserted-by":"crossref","unstructured":"Ferrer I, Aguil\u00f3 Garc\u00eda M, Carmona M, Andr\u00e9s-Benito P, Torrej\u00f3n-Escribano B, Garcia- Esparcia P, Del Rio JA (2019) Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front Aging Neurosci 11:112.","DOI":"10.3389\/fnagi.2019.00112"},{"key":"key-10.4103\/1673-5374.355747-44","doi-asserted-by":"crossref","unstructured":"Finneran DJ, Nash KR (2019) Neuroinflammation and fractalkine signaling in Alzheimer\u2019s disease. J Neuroinflammation 16:30.","DOI":"10.1186\/s12974-019-1412-9"},{"key":"key-10.4103\/1673-5374.355747-45","doi-asserted-by":"crossref","unstructured":"Fisher Y, Nemirovsky A, Baron R, Monsonego A (2010) T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer\u2019s disease. PLoS One 5:e10830.","DOI":"10.1371\/journal.pone.0010830"},{"key":"key-10.4103\/1673-5374.355747-46","doi-asserted-by":"crossref","unstructured":"Fleck D, Phu L, Verschueren E, Hinkle T, Reichelt M, Bhangale T, Haley B, Wang Y, Graham R, Kirkpatrick DS, Sheng M, Bingol B (2019) PTCD1 is required for mitochondrial oxidative-phosphorylation: possible genetic association with Alzheimer\u2019s disease. J Neurosci 39:4636-4656.","DOI":"10.1523\/JNEUROSCI.0116-19.2019"},{"key":"key-10.4103\/1673-5374.355747-47","doi-asserted-by":"crossref","unstructured":"Franco R, Lillo A, Rivas-Santisteban R, Reyes-Resina I, Navarro G (2021) Microglial adenosine receptors: from preconditioning to modulating the M1\/M2 balance in activated cells. Cells 10:1124.","DOI":"10.3390\/cells10051124"},{"key":"key-10.4103\/1673-5374.355747-48","doi-asserted-by":"crossref","unstructured":"Franklin RJ, Goldman SA (2015) Glia disease and repair-remyelination. Cold Spring Harb Perspect Biol 7:a020594.","DOI":"10.1101\/cshperspect.a020594"},{"key":"key-10.4103\/1673-5374.355747-49","doi-asserted-by":"crossref","unstructured":"Frozza RL, Lourenco MV, De Felice FG (2018) Challenges for alzheimer\u2019s disease therapy: insights from novel mechanisms beyond memory defects. Front Neurosci 12:37.","DOI":"10.3389\/fnins.2018.00037"},{"key":"key-10.4103\/1673-5374.355747-50","doi-asserted-by":"crossref","unstructured":"Fumagalli M, Lombardi M, Gressens P, Verderio C (2018) How to reprogram microglia toward beneficial functions. Glia 66:2531-2549.","DOI":"10.1002\/glia.23484"},{"key":"key-10.4103\/1673-5374.355747-51","doi-asserted-by":"crossref","unstructured":"Gaignard P, Fr\u00e9chou M, Liere P, Th\u00e9rond P, Schumacher M, Slama A, Guennoun R (2018) Sex differences in brain mitochondrial metabolism: influence of endogenous steroids and stroke. J Neuroendocrinol doi: 10.1111\/jne.12497.","DOI":"10.1111\/jne.12497"},{"key":"key-10.4103\/1673-5374.355747-52","doi-asserted-by":"crossref","unstructured":"Gaignard P, Fr\u00e9chou M, Schumacher M, Th\u00e9rond P, Mattern C, Slama A, Guennoun R (2016) Progesterone reduces brain mitochondrial dysfunction after transient focal ischemia in male and female mice. J Cereb Blood Flow Metab 36:562-568.","DOI":"10.1177\/0271678X15610338"},{"key":"key-10.4103\/1673-5374.355747-53","doi-asserted-by":"crossref","unstructured":"Garcia-Leon JA, Caceres-Palomo L, Sanchez-Mejias E, Mejias-Ortega M, Nu\u00f1ez-Diaz C, Fernandez-Valenzuela JJ, Sanchez-Varo R, Davila JC, Vitorica J, Gutierrez A (2020) Human pluripotent stem cell-derived neural cells as a relevant platform for drug screening in Alzheimer\u2019s disease. Int J Mol Sci 21:6867.","DOI":"10.3390\/ijms21186867"},{"key":"key-10.4103\/1673-5374.355747-54","doi-asserted-by":"crossref","unstructured":"Garcia-Segura LM, Balthazart J (2009) Steroids and neuroprotection: new advances. Front Neuroendocrinol 30:v-ix.","DOI":"10.1016\/j.yfrne.2009.04.006"},{"key":"key-10.4103\/1673-5374.355747-55","doi-asserted-by":"crossref","unstructured":"Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T (2010) Macrophages in Alzheimer\u2019s disease: the blood-borne identity. J Neural Transm (Vienna) 117:961-970.","DOI":"10.1007\/s00702-010-0422-7"},{"key":"key-10.4103\/1673-5374.355747-56","doi-asserted-by":"crossref","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GK, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM, et al. (2020) Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577:399-404.","DOI":"10.1038\/s41586-019-1895-7"},{"key":"key-10.4103\/1673-5374.355747-57","doi-asserted-by":"crossref","unstructured":"Goshi N, Morgan RK, Lein PJ, Seker E (2020) A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation [published correction appears in J Neuroinflammation. J Neuroinflammation 17:155.","DOI":"10.1186\/s12974-020-01819-z"},{"key":"key-10.4103\/1673-5374.355747-58","doi-asserted-by":"crossref","unstructured":"Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C, Simmons RK, Buckberry S, Vargas-Landin DB, Poppe D, Pflueger J, Lister R, Rackham OJL, Petretto E, Polo JM (2019) A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat Neurosci 22:2087- 2097.","DOI":"10.1038\/s41593-019-0539-4"},{"key":"key-10.4103\/1673-5374.355747-59","doi-asserted-by":"crossref","unstructured":"Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K, Town T (2015) Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85:534-548.","DOI":"10.1016\/j.neuron.2014.12.068"},{"key":"key-10.4103\/1673-5374.355747-60","doi-asserted-by":"crossref","unstructured":"Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, Ciceri G, Sneeboer M, Mazutis L, Setty M, Zumbo P, Betel D, de Witte LD, Pe\u2019er D, Studer L (2021) Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease. Nat Neurosci 24:343-354.","DOI":"10.1038\/s41593-020-00796-z"},{"key":"key-10.4103\/1673-5374.355747-61","doi-asserted-by":"crossref","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nistic\u00f2 R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Tahami Monfared AA, Irizarry M, Albala B, Koyama A, et al. (2021) The \u03b2-Secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry 89:745-756.","DOI":"10.1016\/j.biopsych.2020.02.001"},{"key":"key-10.4103\/1673-5374.355747-62","doi-asserted-by":"crossref","unstructured":"Henstridge CM, Hyman BT, Spires-Jones TL (2019) Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis. Nat Rev Neurosci 20:94-108.","DOI":"10.1038\/s41583-018-0113-1"},{"key":"key-10.4103\/1673-5374.355747-63","doi-asserted-by":"crossref","unstructured":"Henstridge CM, Spires-Jones TL (2018) Modeling Alzheimer\u2019s disease brains in vitro. Nat Neurosci 21:899-900.","DOI":"10.1038\/s41593-018-0177-2"},{"key":"key-10.4103\/1673-5374.355747-64","doi-asserted-by":"crossref","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, Nimmerjahn A, Lemke G (2021) Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol 22:586-594.","DOI":"10.1038\/s41590-021-00913-5"},{"key":"key-10.4103\/1673-5374.355747-65","doi-asserted-by":"crossref","unstructured":"Inoue K (2008) Purinergic systems in microglia. Cell Mol Life Sci 65:3074-3080.","DOI":"10.1007\/s00018-008-8210-3"},{"key":"key-10.4103\/1673-5374.355747-66","doi-asserted-by":"crossref","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Latz E, et al. (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669-673.","DOI":"10.1038\/s41586-019-1769-z"},{"key":"key-10.4103\/1673-5374.355747-67","doi-asserted-by":"crossref","unstructured":"Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246-2254.","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002"},{"key":"key-10.4103\/1673-5374.355747-68","doi-asserted-by":"crossref","unstructured":"Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, Ransohoff RM, Lamb BT, Landreth GE (2017) Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J Neurosci 37:637-647.","DOI":"10.1523\/JNEUROSCI.2110-16.2016"},{"key":"key-10.4103\/1673-5374.355747-69","doi-asserted-by":"crossref","unstructured":"Jord\u00e3o MJC, Sankowski R, Brendecke SM, Sagar, Locatelli G, Tai YH, Tay TL, Schramm E, Armbruster S, Hagemeyer N, Gro\u00df O, Mai D, \u00c7i\u00e7ek \u00d6, Falk T, Kerschensteiner M, Gr\u00fcn D, Prinz M (2019) Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363:eaat7554.","DOI":"10.1126\/science.aat7554"},{"key":"key-10.4103\/1673-5374.355747-70","doi-asserted-by":"crossref","unstructured":"Kabir MT, Uddin MS, Zaman S, Rahman MS, Behl T, Ahmad A, Hafeez A, Perveen A, Ashraf GM (2021) Exploring the anti-neuroinflammatory potential of steroid and terpenoid-derived phytochemicals to combat Alzheimer\u2019s disease. Curr Pharm Des 27:2635- 2647.","DOI":"10.2174\/1381612826666210101152352"},{"key":"key-10.4103\/1673-5374.355747-71","doi-asserted-by":"crossref","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169:1276-1290.e17.","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"key-10.4103\/1673-5374.355747-72","doi-asserted-by":"crossref","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017) Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci 18:419-434.","DOI":"10.1038\/nrn.2017.48"},{"key":"key-10.4103\/1673-5374.355747-73","doi-asserted-by":"crossref","unstructured":"Klegeris A (2021) Regulation of neuroimmune processes by damage- and resolution-associated molecular patterns. Neural Regen Res 16:423-429.","DOI":"10.4103\/1673-5374.293134"},{"key":"key-10.4103\/1673-5374.355747-74","doi-asserted-by":"crossref","unstructured":"Koh YC, Yang G, Lai CS, Weerawatanakorn M, Pan MH (2018) Chemopreventive effects of phytochemicals and medicines on M1\/M2 polarized macrophage role in inflammation-related diseases. Int J Mol Sci 19:2208.","DOI":"10.3390\/ijms19082208"},{"key":"key-10.4103\/1673-5374.355747-75","doi-asserted-by":"crossref","unstructured":"Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.","DOI":"10.1016\/0166-2236(96)10049-7"},{"key":"key-10.4103\/1673-5374.355747-76","doi-asserted-by":"crossref","unstructured":"Krishnan D, Menon RN, Mathuranath PS, Gopala S (2020) A novel role for SHARPIN in amyloid-\u03b2 phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer\u2019s disease. Neurobiol Aging 93:131-141.","DOI":"10.1016\/j.neurobiolaging.2020.02.001"},{"key":"key-10.4103\/1673-5374.355747-77","doi-asserted-by":"crossref","unstructured":"Lana D, Ugolini F, Nosi D, Wenk GL, Giovannini MG (2021) The emerging role of the interplay among astrocytes, microglia, and neurons in the hippocampus in health and disease. Front Aging Neurosci 13:651973.","DOI":"10.3389\/fnagi.2021.651973"},{"key":"key-10.4103\/1673-5374.355747-78","doi-asserted-by":"crossref","unstructured":"Landreth GE, Reed-Geaghan EG (2009) Toll-like receptors in Alzheimer\u2019s disease. Curr Top Microbiol Immunol 336:137-153.","DOI":"10.1007\/978-3-642-00549-7_8"},{"key":"key-10.4103\/1673-5374.355747-79","doi-asserted-by":"crossref","unstructured":"Lau SF, Fu AKY, Ip NY (2021) Cytokine signaling convergence regulates the microglial state transition in Alzheimer\u2019s disease. Cell Mol Life Sci 78:4703-4712.","DOI":"10.1007\/s00018-021-03810-0"},{"key":"key-10.4103\/1673-5374.355747-80","doi-asserted-by":"crossref","unstructured":"Laurent C, Doroth\u00e9e G, Hunot S, Martin E, Monnet Y, Duchamp M, Dong Y, L\u00e9geron FP, Leboucher A, Burnouf S, Faivre E, Carvalho K, Caillierez R, Zommer N, Demeyer D, Jouy N, Sazdovitch V, Schraen-Maschke S, Delarasse C, Bu\u00e9e L, et al. (2016) Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 140:184-200.","DOI":"10.1093\/brain\/aww270"},{"key":"key-10.4103\/1673-5374.355747-81","doi-asserted-by":"crossref","unstructured":"Lay\u00e9 S, Nadjar A, Joffre C, Bazinet RP (2018) Anti-inflammatory effects of Omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology. Pharmacol Rev 70:12-38.","DOI":"10.1124\/pr.117.014092"},{"key":"key-10.4103\/1673-5374.355747-82","doi-asserted-by":"crossref","unstructured":"Lee CY, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm (Vienna) 117:949-960.","DOI":"10.1007\/s00702-010-0433-4"},{"key":"key-10.4103\/1673-5374.355747-83","doi-asserted-by":"crossref","unstructured":"Lee YY, Park JS, Jung JS, Kim DH, Kim HS (2013) Anti-inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells. Int J Mol Sci 14:9820-9833.","DOI":"10.3390\/ijms14059820"},{"key":"key-10.4103\/1673-5374.355747-84","doi-asserted-by":"crossref","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P (2013) The cystine\/ glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18:522-555.","DOI":"10.1089\/ars.2011.4391"},{"key":"key-10.4103\/1673-5374.355747-85","doi-asserted-by":"crossref","unstructured":"Li L, Li R, Zacharek A, Wang F, Landschoot-Ward J, Chopp M, Chen J, Cui X (2020) ABCA1\/ ApoE\/HDL signaling pathway facilitates myelination and oligodendrogenesis after stroke. Int J Mol Sci 21:4369.","DOI":"10.3390\/ijms21124369"},{"key":"key-10.4103\/1673-5374.355747-86","doi-asserted-by":"crossref","unstructured":"Li Q, Barres BA (2018) Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol 18:225-242.","DOI":"10.1038\/nri.2017.125"},{"key":"key-10.4103\/1673-5374.355747-87","doi-asserted-by":"crossref","unstructured":"Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H (2016) Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci 36:577-589.","DOI":"10.1523\/JNEUROSCI.2117-15.2016"},{"key":"key-10.4103\/1673-5374.355747-88","doi-asserted-by":"crossref","unstructured":"Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H (2016) Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci 36:577-589.","DOI":"10.1523\/JNEUROSCI.2117-15.2016"},{"key":"key-10.4103\/1673-5374.355747-89","doi-asserted-by":"crossref","unstructured":"Liddelow SA, Barres BA (2017) Reactive astrocytes: production, function, and therapeutic potential. Immunity 46:957-967.","DOI":"10.1016\/j.immuni.2017.06.006"},{"key":"key-10.4103\/1673-5374.355747-90","doi-asserted-by":"crossref","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481-487.","DOI":"10.1038\/nature21029"},{"key":"key-10.4103\/1673-5374.355747-91","unstructured":"Liu RX, Huang C, Bennett DA, Li H, Wang R (2016) The characteristics of astrocyte on A\u03b2 clearance altered in Alzheimer\u2019s disease were reversed by anti-inflammatory agent (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate. Am J Transl Res 8:4082-4094."},{"key":"key-10.4103\/1673-5374.355747-92","doi-asserted-by":"crossref","unstructured":"Lorenzini L, Fernandez M, Baldassarro VA, Bighinati A, Giuliani A, Calz\u00e0 L, Giardino L (2020) White matter and neuroprotection in Alzheimer\u2019s dementia. Molecules 25:503.","DOI":"10.3390\/molecules25030503"},{"key":"key-10.4103\/1673-5374.355747-93","doi-asserted-by":"crossref","unstructured":"Lueg G, Gross CC, Lohmann H, Johnen A, Kemmling A, Deppe M, Groger J, Minnerup J, Wiendl H, Meuth SG, Duning T (2015) Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer\u2019s disease. Neurobiol Aging 36:81-89.","DOI":"10.1016\/j.neurobiolaging.2014.08.008"},{"key":"key-10.4103\/1673-5374.355747-94","doi-asserted-by":"crossref","unstructured":"Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354-365.","DOI":"10.1016\/j.nurt.2010.05.014"},{"key":"key-10.4103\/1673-5374.355747-95","doi-asserted-by":"crossref","unstructured":"Luo R, Su LY, Li G, Yang J, Liu Q, Yang LX, Zhang DF, Zhou H, Xu M, Fan Y, Li J, Yao YG (2020) Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy 16:52-69.","DOI":"10.1080\/15548627.2019.1596488"},{"key":"key-10.4103\/1673-5374.355747-96","doi-asserted-by":"crossref","unstructured":"Martins RN, Taddei K, Kendall C, Evin G, Bates KA, Harvey AR (2001) Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue. Neuroscience 106:557-569.","DOI":"10.1016\/S0306-4522(01)00289-5"},{"key":"key-10.4103\/1673-5374.355747-97","doi-asserted-by":"crossref","unstructured":"Martins-Ferreira R, Leal B, Costa PP, Ballestar E (2020) Microglial innate memory and epigenetic reprogramming in neurological disorders. Prog Neurobiol 200:101971.","DOI":"10.1016\/j.pneurobio.2020.101971"},{"key":"key-10.4103\/1673-5374.355747-98","doi-asserted-by":"crossref","unstructured":"McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y, Kiss MG, Christie KA, Vinegoni C, Poller WC, Mindur JE, Chan CT, He S, Janssen H, Wong LP, Downey J, Singh S, Anzai A, Kahles F, Jorfi M, et al. (2021) Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease. Nature 595:701-706.","DOI":"10.1038\/s41586-021-03734-6"},{"key":"key-10.4103\/1673-5374.355747-99","doi-asserted-by":"crossref","unstructured":"McGeer PL, McGeer EG (2015) Targeting microglia for the treatment of Alzheimer\u2019s disease. Expert Opin Ther Targets 19:497-506.","DOI":"10.1517\/14728222.2014.988707"},{"key":"key-10.4103\/1673-5374.355747-100","doi-asserted-by":"crossref","unstructured":"McQuade A, Blurton-Jones M (2019) Microglia in Alzheimer\u2019s disease: exploring how genetics and phenotype influence risk. J Mol Biol 431:1805-1817.","DOI":"10.1016\/j.jmb.2019.01.045"},{"key":"key-10.4103\/1673-5374.355747-101","doi-asserted-by":"crossref","unstructured":"Merlo S, Spampinato SF, Caruso GI, Sortino MA (2020) The ambiguous role of microglia in A\u03b2 toxicity: chances for therapeutic intervention. Curr Neuropharmacol 18:446-455.","DOI":"10.2174\/1570159X18666200131105418"},{"key":"key-10.4103\/1673-5374.355747-102","doi-asserted-by":"crossref","unstructured":"Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV (2016) Brain imaging of neurovascular dysfunction in Alzheimer\u2019s disease. Acta Neuropathol 131:687-707.","DOI":"10.1007\/s00401-016-1570-0"},{"key":"key-10.4103\/1673-5374.355747-103","doi-asserted-by":"crossref","unstructured":"Mota M, Porrini V, Parrella E, Benarese M, Bellucci A, Rhein S, Schwaninger M, Pizzi M (2020) Neuroprotective epi-drugs quench the inflammatory response and microglial\/macrophage activation in a mouse model of permanent brain ischemia. J Neuroinflammation 17:361.","DOI":"10.1186\/s12974-020-02028-4"},{"key":"key-10.4103\/1673-5374.355747-104","doi-asserted-by":"crossref","unstructured":"Nair S, Sobotka KS, Joshi P, Gressens P, Fleiss B, Thornton C, Mallard C, Hagberg H (2019) Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia 67:1047-1061.","DOI":"10.1002\/glia.23587"},{"key":"key-10.4103\/1673-5374.355747-105","doi-asserted-by":"crossref","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM (2018) White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun 6:22.","DOI":"10.1186\/s40478-018-0515-3"},{"key":"key-10.4103\/1673-5374.355747-106","doi-asserted-by":"crossref","unstructured":"Neumann H, Takahashi K (2007) Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 184:92-99.","DOI":"10.1016\/j.jneuroim.2006.11.032"},{"key":"key-10.4103\/1673-5374.355747-107","doi-asserted-by":"crossref","unstructured":"Noda M, Suzumura A (2012) Sweepers in the CNS: microglial migration and phagocytosis in the Alzheimer disease pathogenesis. Int J Alzheimers Dis 2012:891087.","DOI":"10.1155\/2012\/891087"},{"key":"key-10.4103\/1673-5374.355747-108","doi-asserted-by":"crossref","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S (2020) Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol 37:101674.","DOI":"10.1016\/j.redox.2020.101674"},{"key":"key-10.4103\/1673-5374.355747-109","doi-asserted-by":"crossref","unstructured":"Osborn O and Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363-374.","DOI":"10.1038\/nm.2627"},{"key":"key-10.4103\/1673-5374.355747-110","doi-asserted-by":"crossref","unstructured":"Ozben T, Ozben S (2019) Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s disease. Clin Biochem 72:87-89.","DOI":"10.1016\/j.clinbiochem.2019.04.001"},{"key":"key-10.4103\/1673-5374.355747-111","doi-asserted-by":"crossref","unstructured":"Pan J, Ma N, Yu B, Zhang W, Wan J (2020) Transcriptomic profiling of microglia and astrocytes throughout aging. J Neuroinflammation17:97.","DOI":"10.1186\/s12974-020-01774-9"},{"key":"key-10.4103\/1673-5374.355747-112","doi-asserted-by":"crossref","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, Liao Y, Yan Y, Li Q, Zhou X, Cheng J, Xing Q, Guan F, Zhang J, Sun L, Yuan Z (2022) Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab 34:634-648.e6.","DOI":"10.1016\/j.cmet.2022.02.013"},{"key":"key-10.4103\/1673-5374.355747-113","doi-asserted-by":"crossref","unstructured":"Park J, Wetzel I, Marriott I, Dr\u00e9au D, D\u2019Avanzo C, Kim DY, Tanzi RE, Cho H (2018) A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat Neurosci 21:941-951.","DOI":"10.1038\/s41593-018-0175-4"},{"key":"key-10.4103\/1673-5374.355747-114","doi-asserted-by":"crossref","unstructured":"Park JS, Kam TI, Lee S, Park H, Oh Y, Kwon SH, Song JJ, Kim D, Kim H, Jhaldiyal A, Na DH, Lee KC, Park EJ, Pomper MG, Pletnikova O, Troncoso JC, Ko HS, Dawson VL, Dawson TM, et al. (2021) Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease. Acta Neuropathol Commun 9:78.","DOI":"10.1186\/s40478-021-01180-z"},{"key":"key-10.4103\/1673-5374.355747-115","doi-asserted-by":"crossref","unstructured":"Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, Hempstead BL, Littman DR, Gan WB (2013) Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155:1596-609.","DOI":"10.1016\/j.cell.2013.11.030"},{"key":"key-10.4103\/1673-5374.355747-116","doi-asserted-by":"crossref","unstructured":"Ploux E, Freret T, Billard JM (2021) d-serine in physiological and pathological brain aging. Biochim Biophys Acta Proteins Proteom 1869:140542.","DOI":"10.1016\/j.bbapap.2020.140542"},{"key":"key-10.4103\/1673-5374.355747-117","doi-asserted-by":"crossref","unstructured":"Podle\u015bny-Drabiniok A, Marcora E, Goate AM (2020) Microglial phagocytosis: a disease-associated process emerging from Alzheimer\u2019s disease genetics. Trends Neurosci 43:965-979.","DOI":"10.1016\/j.tins.2020.10.002"},{"key":"key-10.4103\/1673-5374.355747-118","unstructured":"Preeti K, Sood A, Fernandes V (2021) Metabolic regulation of glia and their neuroinflammatory role in Alzheimer\u2019s disease. Cell Mol Neurobiol doi: 10.1007\/ s10571-021-01147-7."},{"key":"key-10.4103\/1673-5374.355747-119","doi-asserted-by":"crossref","unstructured":"Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer\u2019s disease. Acta Neuropathol 126:461-477.","DOI":"10.1007\/s00401-013-1182-x"},{"key":"key-10.4103\/1673-5374.355747-120","doi-asserted-by":"crossref","unstructured":"Qiao O, Ji H, Zhang Y, Zhang X, Zhang X, Liu N, Huang L, Liu C, Gao W (2021) New insights in drug development for Alzheimer\u2019s disease based on microglia function. Biomed Pharmacother 140:111703.","DOI":"10.1016\/j.biopha.2021.111703"},{"key":"key-10.4103\/1673-5374.355747-121","doi-asserted-by":"crossref","unstructured":"Qin Z, Gu M, Zhou J, Zhang W, Zhao N, L\u00fc Y, Yu W (2020) Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the A\u03b21-42 -induced Alzheimer\u2019s disease mouse model. Synapse 74:e22161.","DOI":"10.1002\/syn.22161"},{"key":"key-10.4103\/1673-5374.355747-122","doi-asserted-by":"crossref","unstructured":"Rajendran L, Paolicelli RC (2018) Microglia-mediated synapse loss in Alzheimer\u2019s disease. J Neurosci 38:2911-2919.","DOI":"10.1523\/JNEUROSCI.1136-17.2017"},{"key":"key-10.4103\/1673-5374.355747-123","doi-asserted-by":"crossref","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI (2018) Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol Neurodegener 13:24.","DOI":"10.1186\/s13024-018-0254-8"},{"key":"key-10.4103\/1673-5374.355747-124","doi-asserted-by":"crossref","unstructured":"Ransohoff RM (2016) A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19:987-991.","DOI":"10.1038\/nn.4338"},{"key":"key-10.4103\/1673-5374.355747-125","doi-asserted-by":"crossref","unstructured":"Rezai-Zadeh K, Gate D, Gowing G, Town T (2011) How to get from here to there: macrophage recruitment in Alzheimer\u2019s disease. Curr Alzheimer Res 8:156-163.","DOI":"10.2174\/156720511795256017"},{"key":"key-10.4103\/1673-5374.355747-126","doi-asserted-by":"crossref","unstructured":"Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G (2021) Common peripheral immunity mechanisms in multiple sclerosis and Alzheimer\u2019s disease. Front Immunol 12:639369.","DOI":"10.3389\/fimmu.2021.639369"},{"key":"key-10.4103\/1673-5374.355747-127","doi-asserted-by":"crossref","unstructured":"Rostami J, Mothes T, Kolahdouzan M, Eriksson O, Moslem M, Bergstr\u00f6m J, Ingelsson M, O\u2019Callaghan P, Healy LM, Falk A, Erlandsson A (2021) Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates. J Neuroinflammation 18:124.","DOI":"10.1186\/s12974-021-02158-3"},{"key":"key-10.4103\/1673-5374.355747-128","doi-asserted-by":"crossref","unstructured":"Sala-Vila A, Arenaza-Urquijo EM, S\u00e1nchez-Benavides G, Su\u00e1rez-Calvet M, Mil\u00e0-Alom\u00e0 M, Grau-Rivera O, Gonz\u00e1lez-de-Ech\u00e1varri JM, Crous-Bou M, Minguill\u00f3n C, Fauria K, Operto G, Falc\u00f3n C, Salvad\u00f3 G, Cacciaglia R, Ingala S, Barkhof F, Schr\u00f6der H, Scarmeas N, Gispert JD, Molinuevo JL (2021) DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease. Am J Clin Nutr 113:1627-1635.","DOI":"10.1093\/ajcn\/nqab016"},{"key":"key-10.4103\/1673-5374.355747-129","first-page":"3240","article-title":"Cells 10:2282","author":"Salcman","year":"2017","journal-title":"Sarlus H, Heneka MT ("},{"key":"key-10.4103\/1673-5374.355747-130","doi-asserted-by":"crossref","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 388:505-517.","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"key-10.4103\/1673-5374.355747-131","doi-asserted-by":"crossref","unstructured":"Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y (2018) Neuroinflammation: microglia and T cells get ready to tango. Front Immunol 8:1905.","DOI":"10.3389\/fimmu.2017.01905"},{"key":"key-10.4103\/1673-5374.355747-132","doi-asserted-by":"crossref","unstructured":"Sears SM, Hewett SJ (2021) Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance. Exp Biol Med (Maywood) 246:1069-1083.","DOI":"10.1177\/1535370221989263"},{"key":"key-10.4103\/1673-5374.355747-133","doi-asserted-by":"crossref","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595-608.","DOI":"10.15252\/emmm.201606210"},{"key":"key-10.4103\/1673-5374.355747-134","doi-asserted-by":"crossref","unstructured":"Seol Y, Ki S, Ryu HL, Chung S, Lee J, Ryu H (2020) How microglia manages non-cell autonomous vicious cycling of A\u03b2 toxicity in the pathogenesis of AD. Front Mol Neurosci 13:593724.","DOI":"10.3389\/fnmol.2020.593724"},{"key":"key-10.4103\/1673-5374.355747-135","doi-asserted-by":"crossref","unstructured":"Shechter R, Miller O, Yovel G, Rosenzweig N, London A, Ruckh J, Kim KW, Klein E, Kalchenko V, Bendel P, Lira SA, Jung S, Schwartz M (2013) Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38:555-569.","DOI":"10.1016\/j.immuni.2013.02.012"},{"key":"key-10.4103\/1673-5374.355747-136","doi-asserted-by":"crossref","unstructured":"Shi Y, Holtzman DM (2018) Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol 18:759-772.","DOI":"10.1038\/s41577-018-0051-1"},{"key":"key-10.4103\/1673-5374.355747-137","doi-asserted-by":"crossref","unstructured":"Simon E, Obst J, Gomez-Nicola D (2019) The evolving dialogue of microglia and neurons in alzheimer\u2019s disease: microglia as necessary transducers of pathology. Neuroscience 405:24-34.","DOI":"10.1016\/j.neuroscience.2018.01.059"},{"key":"key-10.4103\/1673-5374.355747-138","doi-asserted-by":"crossref","unstructured":"Sipe GO, Lowery RL, Tremblay M\u00c8, Kelly EA, Lamantia CE, Majewska AK (2016) Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun7:10905.","DOI":"10.1038\/ncomms10905"},{"key":"key-10.4103\/1673-5374.355747-139","doi-asserted-by":"crossref","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P (2018) An inflammation-centric view of neurological disease: beyond the neuron. Front Cell Neurosci 12:72.","DOI":"10.3389\/fncel.2018.00072"},{"key":"key-10.4103\/1673-5374.355747-140","doi-asserted-by":"crossref","unstructured":"Spangenberg EE, Green KN (2017) Inflammation in Alzheimer\u2019s disease: lessons learned from microglia-depletion models. Brain Behav Immun 61:1-11.","DOI":"10.1016\/j.bbi.2016.07.003"},{"key":"key-10.4103\/1673-5374.355747-141","doi-asserted-by":"crossref","unstructured":"Spiteri AG, Wishart CL, King NJC (2020) Immovable object meets unstoppable force? dialogue between resident and peripheral myeloid cells in the inflamed brain. Front Immunol 11:600822.","DOI":"10.3389\/fimmu.2020.600822"},{"key":"key-10.4103\/1673-5374.355747-142","doi-asserted-by":"crossref","unstructured":"Stalder M, Deller T, Staufenbiel M, Jucker M (2001) 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging 22:427-34.","DOI":"10.1016\/S0197-4580(01)00209-3"},{"key":"key-10.4103\/1673-5374.355747-143","doi-asserted-by":"crossref","unstructured":"Stolero N, Frenkel D (2021) The dialog between neurons and microglia in Alzheimer\u2019s disease: The neurotransmitters view. J Neurochem 158:1412-1424.","DOI":"10.1111\/jnc.15262"},{"key":"key-10.4103\/1673-5374.355747-144","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133-150.","DOI":"10.1038\/nrneurol.2017.188"},{"key":"key-10.4103\/1673-5374.355747-145","doi-asserted-by":"crossref","unstructured":"Tajbakhsh A, Read M, Barreto GE, \u00c1vila-Rodriguez M, Gheibi-Hayat SM, Sahebkar A (2021) Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer\u2019s disease: pathological mechanisms and therapeutic outlooks. Eur J Pharmacol 895:173873.","DOI":"10.1016\/j.ejphar.2021.173873"},{"key":"key-10.4103\/1673-5374.355747-146","doi-asserted-by":"crossref","unstructured":"Tang M, Taghibiglou C (2017) The Mechanisms of action of curcumin in Alzheimer\u2019s disease. J Alzheimers Dis 58:1003-1016.","DOI":"10.3233\/JAD-170188"},{"key":"key-10.4103\/1673-5374.355747-147","doi-asserted-by":"crossref","unstructured":"Tang Y (2018) Editorial: microglial polarization in the pathogenesis and therapeutics of neurodegenerative diseases. Front Aging Neurosci 10:154.","DOI":"10.3389\/fnagi.2018.00154"},{"key":"key-10.4103\/1673-5374.355747-148","doi-asserted-by":"crossref","unstructured":"Tang Y, Li X, Mao X (2019) Editorial: linking neuroinflammation and glial phenotypic changes in neurological diseases. Front Cell Neurosci13:542.","DOI":"10.3389\/fncel.2019.00542"},{"key":"key-10.4103\/1673-5374.355747-149","doi-asserted-by":"crossref","unstructured":"Teter B, Morihara T, Lim GP, Chu T, Jones MR, Zuo X, Paul RM, Frautschy SA, Cole GM (2019) Curcumin restores innate immune Alzheimer\u2019s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiol Dis 127:432-448.","DOI":"10.1016\/j.nbd.2019.02.015"},{"key":"key-10.4103\/1673-5374.355747-150","doi-asserted-by":"crossref","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541-5554.","DOI":"10.2147\/IJN.S200490"},{"key":"key-10.4103\/1673-5374.355747-151","doi-asserted-by":"crossref","unstructured":"Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, Oda T, Tsuchiya K, Kosaka K (2002) Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases. J Neuroimmunol 124:83-92.","DOI":"10.1016\/S0165-5728(01)00496-9"},{"key":"key-10.4103\/1673-5374.355747-152","doi-asserted-by":"crossref","unstructured":"Tublin JM, Adelstein JM, Del Monte F, Combs CK, Wold LE (2019) Getting to the heart of Alzheimer disease. Circ Res 124:142-149.","DOI":"10.1161\/CIRCRESAHA.118.313563"},{"key":"key-10.4103\/1673-5374.355747-153","doi-asserted-by":"crossref","unstructured":"Ulland TK, Colonna M (2018) TREM2 -a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 14:667-675.","DOI":"10.1038\/s41582-018-0072-1"},{"key":"key-10.4103\/1673-5374.355747-154","doi-asserted-by":"crossref","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystr\u00f6m S, Nilsson KP, Song WM, Zhou Y, Reinartz M, Choi S, Jiang H, Stewart FR, Anderson E, Wang Y, Colonna M, Holtzman DM (2018) ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med 215:1047-1058.","DOI":"10.1084\/jem.20171265"},{"key":"key-10.4103\/1673-5374.355747-155","doi-asserted-by":"crossref","unstructured":"Unger MS, Li E, Scharnagl L, Poupardin R, Altendorfer B, Mrowetz H, Hutter-Paier B, Weiger TM, Heneka MT, Attems J, Aigner L (2020) CD8+ T-cells infiltrate Alzheimer\u2019s disease brains and regulate neuronal-and synapse-related gene expression in APPPS1 transgenic mice. Brain Behav Immun 89:67-86.","DOI":"10.1016\/j.bbi.2020.05.070"},{"key":"key-10.4103\/1673-5374.355747-156","doi-asserted-by":"crossref","unstructured":"Vacinova G, Vejra\u017ekova D, Rusina R, Holmerov\u00e1 I, Va\u0148kov\u00e1 H, Jarol\u00edmov\u00e1 E, V\u010del\u00e1k J, Bendlov\u00e1 B, Va\u0148kov\u00e1 M (2021) Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer\u2019s disease. Neural Regen Res 16:796-800.","DOI":"10.4103\/1673-5374.295340"},{"key":"key-10.4103\/1673-5374.355747-157","doi-asserted-by":"crossref","unstructured":"van Assema DM, Lubberink M, Rizzu P, van Swieten JC, Schuit RC, Eriksson J, Scheltens P, Koepp M, Lammertsma AA, van Berckel BN (2012) Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer\u2019s disease patients: effect of polymorphisms in the ABCB1 gene. EJNMMI Res 2:57.","DOI":"10.1186\/2191-219X-2-57"},{"key":"key-10.4103\/1673-5374.355747-158","doi-asserted-by":"crossref","unstructured":"van de Haar HJ, Burgmans S, Jansen JF, van Osch MJ, van Buchem MA, Muller M, Hofman PA, Verhey FR, Backes WH (2016) Blood-Brain Barrier leakage in patients with early Alzheimer disease. Radiology 281:527-535.","DOI":"10.1148\/radiol.2016152244"},{"key":"key-10.4103\/1673-5374.355747-159","doi-asserted-by":"crossref","unstructured":"van Olst L, Verhaege D, Franssen M, Kamermans A, Roucourt B, Carmans S, Ytebrouck E, van der Pol SMA, Wever D, Popovic M, Vandenbroucke RE, Sobrino T, Schouten M, de Vries HE (2020) Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model. Neurobiol Aging 89:89-98.","DOI":"10.1016\/j.neurobiolaging.2020.01.003"},{"key":"key-10.4103\/1673-5374.355747-160","doi-asserted-by":"crossref","unstructured":"Villani A, Benjaminsen J, Moritz C, Henke K, Hartmann J, Norlin N, Richter K, Schieber NL, Franke T, Schwab Y, Peri F (2019) Clearance by microglia depends on packaging of phagosomes into a unique cellular compartment. Dev Cell 49:77-88.e7.","DOI":"10.1016\/j.devcel.2019.02.014"},{"key":"key-10.4103\/1673-5374.355747-161","doi-asserted-by":"crossref","unstructured":"Wang L, Yu CC, Liu XY, Deng XN, Tian Q, Du YJ (2021) Epigenetic modulation of microglia function and phenotypes in neurodegenerative diseases. Neural Plast 2021:9912686.","DOI":"10.1155\/2021\/9912686"},{"key":"key-10.4103\/1673-5374.355747-162","doi-asserted-by":"crossref","unstructured":"Wang Q, Xu Y, Qi C, Liu A, Zhao Y (2020) Association study of serum soluble TREM2 with vascular dementia in Chinese Han population. Int J Neurosci 130:708-712.","DOI":"10.1080\/00207454.2019.1702548"},{"key":"key-10.4103\/1673-5374.355747-163","doi-asserted-by":"crossref","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis 57:1041-1048.","DOI":"10.3233\/JAD-160763"},{"key":"key-10.4103\/1673-5374.355747-164","doi-asserted-by":"crossref","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S, Cella M, Grutzendler J, DeMattos RB, Cirrito JR, Holtzman DM, Colonna M (2016) TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med 213:667-675.","DOI":"10.1084\/jem.20151948"},{"key":"key-10.4103\/1673-5374.355747-165","doi-asserted-by":"crossref","unstructured":"Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ (2001) Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol 166:7496-503.","DOI":"10.4049\/jimmunol.166.12.7496"},{"key":"key-10.4103\/1673-5374.355747-166","doi-asserted-by":"crossref","unstructured":"Wei W, Wang Y, Zhang J, Gu Q, Liu X, Song L, Chai Z, Guo M, Yu J, Ma C (2021) Fasudil ameliorates cognitive deficits, oxidative stress and neuronal apoptosis via inhibiting ROCK\/MAPK and activating Nrf2 signalling pathways in APP\/PS1 mice. Folia Neuropathol 59:32-49.","DOI":"10.5114\/fn.2021.105130"},{"key":"key-10.4103\/1673-5374.355747-167","doi-asserted-by":"crossref","unstructured":"Weinhard L, di Bartolomei G, Bolasco G, Machado P, Schieber NL, Neniskyte U, Exiga M, Vadisiute A, Raggioli A, Schertel A, Schwab Y, Gross CT (2018) Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun 9:1228.","DOI":"10.1038\/s41467-018-03566-5"},{"key":"key-10.4103\/1673-5374.355747-168","doi-asserted-by":"crossref","unstructured":"Whitelaw BS (2018) Microglia-mediated synaptic elimination in neuronal development and disease. J Neurophysiol 119:1-4.","DOI":"10.1152\/jn.00021.2017"},{"key":"key-10.4103\/1673-5374.355747-169","doi-asserted-by":"crossref","unstructured":"Wisniewski HM, Barcikowska M, Kida E (1991) Phagocytosis of beta\/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol 81:588-590.","DOI":"10.1007\/BF00310142"},{"key":"key-10.4103\/1673-5374.355747-170","doi-asserted-by":"crossref","unstructured":"Wright-Jin EC, Gutmann DH (2019) Microglia as dynamic cellular mediators of brain function. Trends Mol Med 25:967-979.","DOI":"10.1016\/j.molmed.2019.08.013"},{"key":"key-10.4103\/1673-5374.355747-171","doi-asserted-by":"crossref","unstructured":"Wu Q, Kong W, Wang S (2021) Peripheral blood biomarkers CXCL12 and TNFRSF13C associate with cerebrospinal fluid biomarkers and infiltrating immune cells in Alzheimer disease. J Mol Neurosci 71:1485-1494.","DOI":"10.1007\/s12031-021-01809-7"},{"key":"key-10.4103\/1673-5374.355747-172","doi-asserted-by":"crossref","unstructured":"Wyatt-Johnson SK, Brutkiewicz RR (2020) The complexity of microglial interactions with innate and adaptive immune cells in Alzheimer\u2019s disease. Front Aging Neurosci 12:592359.","DOI":"10.3389\/fnagi.2020.592359"},{"key":"key-10.4103\/1673-5374.355747-173","doi-asserted-by":"crossref","unstructured":"Xiang J, Yang F, Zhu W, Cai M, Li XT, Zhang JS, Yu ZH, Zhang W, Cai DF (2021) Bilobalide inhibits inflammation and promotes the expression of A\u03b2 degrading enzymes in astrocytes to rescue neuronal deficiency in AD models. Transl Psychiatry 11:542.","DOI":"10.1038\/s41398-021-01594-2"},{"key":"key-10.4103\/1673-5374.355747-174","doi-asserted-by":"crossref","unstructured":"Xie L, Zhang N, Zhang Q, Li C, Sandhu AF, Iii GW, Lin S, Lv P, Liu Y, Wu Q, Yu S (2020) Inflammatory factors and amyloid \u03b2-induced microglial polarization promote inflammatory crosstalk with astrocytes. Aging (Albany NY) 12:22538-22549.","DOI":"10.18632\/aging.103663"},{"key":"key-10.4103\/1673-5374.355747-175","doi-asserted-by":"crossref","unstructured":"Yang J, Wise L, Fukuchi KI (2020) TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front Immunol 11:724.","DOI":"10.3389\/fimmu.2020.00724"},{"key":"key-10.4103\/1673-5374.355747-176","doi-asserted-by":"crossref","unstructured":"Yang M, Yang Z, Wang P, Sun Z (2021) Current application and future directions of photobiomodulation in central nervous diseases. Neural Regen Res 16:1177-1185.","DOI":"10.4103\/1673-5374.300486"},{"key":"key-10.4103\/1673-5374.355747-177","doi-asserted-by":"crossref","unstructured":"Yang S, Magnutzki A, Alami NO, Lattke M, Hein TM, Scheller JS, Kr\u00f6ger C, Oswald F, Yilmazer-Hanke D, Wirth T, Baumann B (2021) IKK2\/NF-\u03baB activation in astrocytes reduces amyloid \u03b2 deposition: a process associated with specific microglia polarization. Cells 10:2669.","DOI":"10.3390\/cells10102669"},{"key":"key-10.4103\/1673-5374.355747-178","doi-asserted-by":"crossref","unstructured":"Yao K, Zu HB (2019) Microglial polarization: novel therapeutic mechanism against Alzheimer\u2019s disease. Inflammopharmacology 28:95-110.","DOI":"10.1007\/s10787-019-00613-5"},{"key":"key-10.4103\/1673-5374.355747-179","doi-asserted-by":"crossref","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 Binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91:328-340.","DOI":"10.1016\/j.neuron.2016.06.015"},{"key":"key-10.4103\/1673-5374.355747-180","doi-asserted-by":"crossref","unstructured":"Yossef RR, Al-Yamany MF, Saad MA, El-Sahar AE (2020) Neuroprotective effects of vildagliptin on drug induced Alzheimer\u2019s disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways. Eur J Pharmacol 889:173612.","DOI":"10.1016\/j.ejphar.2020.173612"},{"key":"key-10.4103\/1673-5374.355747-181","doi-asserted-by":"crossref","unstructured":"Yu T, Lin Y, Xu Y, Dou Y, Wang F, Quan H, Zhao Y, Liu X (2020) Repressor element 1 silencing transcription factor (REST) governs microglia-like BV2 cell migration via progranulin (PGRN). Neural Plast 2020:8855822.","DOI":"10.1155\/2020\/8855822"},{"key":"key-10.4103\/1673-5374.355747-182","doi-asserted-by":"crossref","unstructured":"Z\u00e1dori D, Veres G, Szal\u00e1rdy L, Kliv\u00e9nyi P, V\u00e9csei L (2018) Alzheimer\u2019s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines. J Alzheimers Dis 62:523-547.","DOI":"10.3233\/JAD-170929"},{"key":"key-10.4103\/1673-5374.355747-183","doi-asserted-by":"crossref","unstructured":"Zhang J, Ke KF, Liu Z, Qiu YH, Peng YP (2013) Th17 cell-mediated neuroinflammation is involved in neurodegeneration of a\u03b21-42-induced Alzheimer\u2019s disease model rats. PLoS One 8:e75786.","DOI":"10.1371\/journal.pone.0075786"},{"key":"key-10.4103\/1673-5374.355747-184","doi-asserted-by":"crossref","unstructured":"Zhang L, Xu J, Gao J, Wu Y, Yin M, Zhao W (2018a) CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer\u2019s disease. Rev Neurosci 29:837-848.","DOI":"10.1515\/revneuro-2017-0084"},{"key":"key-10.4103\/1673-5374.355747-185","doi-asserted-by":"crossref","unstructured":"Zhang M, Qian C, Zheng ZG, Qian F, Wang Y, Thu PM, Zhang X, Zhou Y, Tu L, Liu Q, Li HJ, Yang H, Li P, Xu X (2018b) Jujuboside A promotes A\u03b2 clearance and ameliorates cognitive deficiency in Alzheimer\u2019s disease through activating Axl\/HSP90\/PPAR\u03b3 pathway. Theranostics 8:4262-4278.","DOI":"10.7150\/thno.26164"},{"key":"key-10.4103\/1673-5374.355747-186","doi-asserted-by":"crossref","unstructured":"Zhang X, Ye P, Wang D, Liu Y, Cao L, Wang Y, Xu Y, Zhu C (2019) Involvement of rhoa\/ rock signaling in a\u03b2-induced chemotaxis, cytotoxicity and inflammatory response of microglial BV2 cells. Cell Mol Neurobiol 39:637-650.","DOI":"10.1007\/s10571-019-00668-6"},{"key":"key-10.4103\/1673-5374.355747-187","doi-asserted-by":"crossref","unstructured":"Zhang YS, Tang LJ, Tu H, Wang SJ, Liu B, Zhang XJ, Li NS, Luo XJ, Peng J (2018c) Fasudil ameliorates the ischemia\/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain\/NADPH oxidase 2 pathway. Eur J Pharmacol 822:1-12.","DOI":"10.1016\/j.ejphar.2018.01.007"},{"key":"key-10.4103\/1673-5374.355747-188","doi-asserted-by":"crossref","unstructured":"Zhao L (2019) CD33 in Alzheimer\u2019s disease -biology, pathogenesis, and therapeutics: a mini-review. Gerontology 65:323-331.","DOI":"10.1159\/000492596"},{"key":"key-10.4103\/1673-5374.355747-189","doi-asserted-by":"crossref","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, Cella M, Ulland TK, Zaitsev K, Miyashita A, Ikeuchi T, Sainouchi M, Kakita A, Bennett DA, Schneider JA, Nichols MR, et al. (2020) Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med 26:131-142.","DOI":"10.1038\/s41591-019-0695-9"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:15:19Z","timestamp":1787066119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.355747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":189,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["355747"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.355747","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}